All biomarkers were significantly higher in AKI than in CKD patients, except uromodulin that was lower in AKI (35 ng/ml ±3.8) verses CKD (41.7 ng/ml±14.3) patients (Table-I). This evidence concerns the gene UMOD and chronic kidney disease.